Abstract:Gene dosage variations occur in many diseases. In cancer, deletions and copy number increases contribute to alterations in the expression of tumour-suppressor genes and oncogenes, respectively. Developmental abnormalities, such as Down, Prader Willi, Angelman and Cri du Chat syndromes, result from gain or loss of one copy of a chromosome or chromosomal region. Thus, detection and mapping of copy number abnormalities provide an approach for associating aberrations with disease phenotype and for localizing critical genes. Comparative genomic hybridization3(CGH) was developed for genome-wide analysis of DNA sequence copy number in a single experiment. In CGH, differentially labelled total genomic DNA from a 'test' and a 'reference' cell population are cohybridized to normal metaphase chromosomes, using blocking DNA to suppress signals from repetitive sequences. The resulting ratio of the fluorescence intensities at a location on the 'cytogenetic map', provided by the chromosomes, is approximately proportional to the ratio of the copy numbers of the corresponding DNA sequences in the test and reference genomes. CGH has been broadly applied to human and mouse malignancies. The use of metaphase chromosomes, however, limits detection of events involving small regions (of less than 20 Mb) of the genome, resolution of closely spaced aberrations and linking ratio changes to genomic/genetic markers. Therefore, more laborious locus-by-locus techniques have been required for higher resolution studies2,3,4,5. Hybridization to an array of mapped sequences instead of metaphase chromosomes could overcome the limitations of conventional CGH (ref. 6) if adequate performance could be achieved. Copy number would be related to the test/reference fluorescence ratio on the array targets, and genomic resolution could be determined by the map distance between the targets, or by the length of the cloned DNA segments. We describe here our implementation of array CGH. We demonstrate its ability to measure copy number with high precision in the human genome, and to analyse clinical specimens by obtaining new information on chromosome 20 aberrations in breast cancer.

PCR amplicons identify widespread copy number variation in human centromeric arrays and instability in cancer.

Segmental Duplications and Copy-Number Variation in the Human Genome

Centromere reference models for human chromosomes X and Y satellite arrays

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

Abstract 4338: A pan-cancer single-cell analysis of intratumoral copy number diversity and evolution

Copy Number Aberrations from Affymetrix SNP 6.0 Genotyping Data-How Accurate Are Commonly Used Prediction Approaches?

Genome-wide analysis of DNA copy-number changes using cDNA microarrays

Ribosomal DNA Copy Number Loss and Sequence Variation in Cancer

Copy Number Analysis Of Whole-Genome Data Using Bic-Seq2 And Its Application To Detection Of Cancer Susceptibility Variants

Copy-number-variation and copy-number-alteration region detection by cumulative plots

Performance Assessment of Copy Number Microarray Platforms Using a Spike-in Experiment.

Methods and strategies for analyzing copy number variation using DNA microarrays

Large-scale Copy Number Variants (cnvs): Distribution in Normal Subjects and FISH/real-time Qpcr Analysis

Global Diversity, Population Stratification, and Selection of Human Copy-Number Variation

Characterization of 26 Deletion CNVs Reveals the Frequent Occurrence of Micro-Mutations Within the Breakpoint-Flanking Regions and Frequent Repair of Double-Strand Breaks by Templated Insertions Derived from Remote Genomic Regions

Signatures of copy number alterations in human cancer

The variation and evolution of complete human centromeres

Centromere landscapes resolved from hundreds of human genomes

A Single Cell Level Based Method For Copy Number Variation Analysis By Low Coverage Massively Parallel Sequencing

Standardization and Diversification of Copy Number Microarray Testing for Clinical Diagnostics—Implications of the Cross-Platform/Algorithm Study on Clinical Diagnostic Chromosomal Microarray Analysis

Density Matters: Comparison of Array Platforms for Detection of Copy-Number Variation and Copy-Neutral Abnormalities.